|
vitamin d |
21 |
|
coronary artery disease |
15 |
|
type 2 diabetes |
14 |
|
type 2 diabetes mellitus |
13 |
|
ischemic stroke |
12 |
|
myocardial infarction |
12 |
|
recurrence |
12 |
|
secondary prevention |
12 |
|
adipocyte |
10 |
|
b-type natriuretic peptide |
10 |
|
cardiac troponin |
10 |
|
fibroblast growth factor |
10 |
|
lipocalin-2 |
10 |
|
risk factor |
10 |
|
risk prediction |
10 |
|
asian-specific |
9 |
|
atrial fibrillation |
9 |
|
exome-chip association analysis |
9 |
|
mendelian randomization |
9 |
|
pax4 |
9 |
|
sex disparity |
9 |
|
young-onset ischemic stroke |
9 |
|
autoimmunity |
8 |
|
covid-19 |
8 |
|
diabetic retinopathy |
8 |
|
genetic variants |
8 |
|
genome-wide association studies |
8 |
|
insr |
8 |
|
interferon beta-1b |
8 |
|
prediction model |
8 |
|
proliferative diabetic retinopathy |
8 |
|
sars-cov-2 |
8 |
|
sight-threatening diabetic retinopathy |
8 |
|
thyroid function tests |
8 |
|
diabetes mellitus |
7 |
|
dpp4 inhibitor |
7 |
|
fib-4 |
7 |
|
glp1 receptor agonists |
7 |
|
metabolic dysfunction–associated steatohepatitis |
7 |
|
nfs |
7 |
|
pioglitazone |
7 |
|
sglt2 inhibitor |
7 |
|
sglt2 inhibitors |
7 |
|
adult |
6 |
|
aged |
6 |
|
alzheimer's disease |
6 |
|
asian continental ancestry group - genetics |
6 |
|
chinese |
6 |
|
diabetes |
6 |
|
diabetes mellitus, type 2 - diagnosis - ethnology - genetics |
6 |
|
genetic predisposition to disease |
6 |
|
genetic predisposition to disease - genetics |
6 |
|
genetic variation |
6 |
|
genotype |
6 |
|
glycaemia |
6 |
|
hba1c variability |
6 |
|
medical sciences |
6 |
|
metabolic syndrome x - genetics |
6 |
|
obesity - genetics |
6 |
|
obesity - genetics - metabolism |
6 |
|
polymorphism, genetic |
6 |
|
polymorphism, single nucleotide - genetics |
6 |
|
potassium channels, inwardly rectifying - genetics |
6 |
|
prediabetic state - diagnosis - ethnology - genetics |
6 |
|
adipocyte fatty acid-binding protein |
5 |
|
adipokine |
5 |
|
adiponectin |
5 |
|
adverse cardiovascular outcomes |
5 |
|
anti-oxidant |
5 |
|
cancer |
5 |
|
cardiovascular disease |
5 |
|
coronary heart disease |
5 |
|
diacylglycerol |
5 |
|
glucose-stimulated insulin secretion |
5 |
|
lipidomic study |
5 |
|
lyso-phosphatidylcholine |
5 |
|
microvascular complications |
5 |
|
multiple endocrine neoplasia |
5 |
|
nephropathy |
5 |
|
paraganglioma |
5 |
|
pheochromocytoma |
5 |
|
primary prevention |
5 |
|
succinate dehydrogenase |
5 |
|
triacylglycerol |
5 |
|
vitamin a |
5 |
|
vitamin c |
5 |
|
vitamin e |
5 |
|
non-insulin-dependent diabetes - china - hong kong - genetic aspects. |
2 |
|
obesity - china - hong kong - genetic aspects. |
2 |
